Galvani Bioelectronics, a clinical-stage therapeutics company resulting from a partnership between GSK and Verily Life Sciences, has initiated recruitment for the randomized, controlled phase of a clinical feasibility study targeting patients with Rheumatoid Arthritis (RA). This advancement follows FDA approval,…
Research findings published today in the peer-reviewed Journal of Clinical Oncology by NMDP℠ and CIBMTR® (Center for International Blood and Marrow Transplant Research®) indicate that there is no significant difference in overall survival (OS) for patients with blood cancer undergoing…
Sensorion (FR0012596468 – ALSEN), a pioneering biotechnology company specializing in hearing loss disorders, has unveiled new positive findings from its SENS-401 Phase 2a clinical trial. The data, focusing on the preservation of residual hearing following cochlear implantation in adult patients,…
Diakonos Oncology Corporation (“Diakonos”), a pioneer in immuno-oncology, announced today that its dendritic cell vaccine (DCV) for pancreatic ductal adenocarcinoma has received Fast Track designation from the U.S. Food and Drug Administration (FDA). This recognition highlights the potential of Diakonos’…
Teladoc Health (NYSE: TDOC), a global leader in comprehensive virtual care, is providing complimentary 24/7 general medical telehealth consultations to Texas residents, first responders, and others directly impacted by Hurricane Beryl. Texas individuals displaced or unable to access traditional medical…
Agilon Health, Inc. (NYSE: AGL), a leader in empowering physicians to innovate healthcare delivery, announced today the appointment of Dr. Karthik Rao as permanent Chief Medical Officer (CMO), effective immediately. Dr. Rao, who has been serving as agilon’s interim CMO…
Henry Schein, Inc. (Nasdaq: HSIC), a global leader in providing healthcare solutions to dental and medical offices, celebrated the launch of its new 811,000-square-foot Southwestern Distribution Center located in Fort Worth, Texas. This facility stands as the largest single building…
Baxter International Inc. (NYSE), a global medtech leader, has published its 2023 Corporate Responsibility Report, highlighting its ongoing commitment to impactful global healthcare and transparent reporting on environmental, social, and governance issues crucial to stakeholders. José (Joe) E. Almeida, chair,…
WellCare of North Carolina, a Medicaid health plan under Centene Corporation (NYSE: CNC), has earned Health Equity Accreditation from the National Committee for Quality Assurance (NCQA) earlier than the mandated mid-year 2025 deadline. This achievement highlights WellCare’s strong commitment to…
DKMS and the SBB Research Group Foundation collaborated on a volunteer initiative, part of the Champion A Charity Program, supporting local nonprofits. At Night Shift Brewing near Boston, Massachusetts, a charitable event unfolded as DKMS found a staunch advocate in…
EO Care, a leader in clinically guided cannabinoid-based healthcare treatment, announced today that Milliman, a premier global consulting and actuarial firm, has completed its review of EO Care’s proprietary cost impact model. This model is designed for employers and group…
Zura Bio Limited (NASDAQ: ZURA), a clinical-stage immunology company specializing in novel dual-pathway antibodies for autoimmune and inflammatory diseases, has announced the commencement of an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) concerning its outstanding IPO warrants.…